Opening Address: State of the Consortium

Begin the day's proceedings with an opening address by John Wherry. His talk will set the context for the seminar by providing an update on the current state and future direction of the consortium.

NYU Center Overview

Dr. Jose Scher is the Steere Abramson Associate Professor of Medicine, Director of the NYU Colton Center for Autoimmunity, Associate Director of Research and Translational Medicine for the Division of Rheumatology, and the Director of the Psoriatic Arthritis Center at New York University School of Medicine in New York, NY. He received his M.D. in Buenos Aires, Argentina, and completed his internal medicine residency and rheumatology fellowship at NYU. His research interests include the immune and environmental features that enhance risk for transition from psoriasis to PsA, the mechanisms behind microbiome perturbations in psoriatic and rheumatoid disease, and the pharmacomicrobiomics of DMARDs and immunotherapies in human RA and PsA. His work is supported by grants from the NIH/NIAMS, the Rheumatology Research Foundation, National Psoriasis Foundation, and Bloomberg Philanthropies, among others. Dr. Scher is a founding member of the Psoriasis and Psoriatic Arthritis Collaborative Multicenter Advancement Network (PPACMAN) and directs since 2015 the NYU Advance Course in Psoriasis and Psoriatic Arthritis. He is past member of the FDAs Arthritis Advisory Committee (2016-2020), and currently serves as chair of the NPF Scientific Advisory Committee (2021) and as standing member of the NIH-ACTS study section (2021).

Yale Center Overview